This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IPad Altering Interaction Between Pharma Sales Forces, Physicians, & Consumers

CHAPEL HILL, N.C., Feb. 1, 2013 /PRNewswire/ -- The integration of the iPad into the pharmaceutical industry has had a substantial impact on the sector's interactions with physicians and payers. The growth of tablet technology is rapidly transforming how field sales forces in the pharmaceutical industry communicate with physicians and payers.

While the implementation of the iPad has been rapid and exponential, effectively integrating iPads into the field requires significant planning and training to make the investment a success. A new benchmark study completed by research and consulting firm Best Practices, LLC uncovered strategies for measuring the effectiveness of the iPad as an inventive sales tool.

The report, Deploying the iPad to Sales & Managed Markets Teams: Training and Effectiveness Benchmark, focuses on key challenges and best practices when deploying iPads or Android-Based tablets to large customer-facing commercial groups within pharmaceutical and medical device organizations.

Among the findings that Best Practices uncovered:
  • Approximately one in five companies have already issued iPads to their managed markets teams, with an overall majority of benchmark companies planning to do so in the next 12 months.

The 66-page report contains over 130 metrics and 41 narratives to provide biopharmaceutical leaders with an evidence-based understanding of how other companies in the pharmaceutical and medical device industries are attempting to align their resources and activities to ensure the continuity of their sales' processes.

Key Topics of this report include:
  • Training
  • Systems Integration and Application Development
  • Security and Compliance
  • Applications that Increase Productivity
  • Field Usage and Measuring Effectiveness
  • Challenges and Best Practices in Making the Investment a Success

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1168.htm.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

ABOUT BEST PRACTICES, LLC Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

SOURCE Best Practices, LLC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.12 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs